undamentalytics Newsletter
Sign in

Cvrx, Inc. revenue

Cvrx, Inc.'s revenue was $56.7m in fiscal 2025, up 10.4% on the year before. Since fiscal 2020 ($6.1m) it has grown at a compound 56.4% a year. Over the last twelve months it was $61.2m.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue6132239515761
Growth on the year before—+115.4%+72.4%+74.9%+30.5%+10.4%—
Gross profit591733434853
Gross margin76.2%72.1%77.8%84.1%83.8%85.3%86.9%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 31, 2025
Geography
Region Revenue Share YoY
United States $51.9M 91.6% ▲ 10.0%
Germany $4.8M 8.4% ▲ 15.6%

From Cvrx, Inc.'s 10-K filed February 13, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Health Care Equipment: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Cvrx, Inc. $61.2m 12.0% 25.7%
Alpha PRO Tech LTD $61.9m 5.7% 2.9%
Lensar, Inc. $60.3m 3.3% 16.4%
Apyx Medical Corp $58.4m 25.6% 7.2%
Iridex Corp $51.6m 3.7% -2.9%
Electromed, Inc. $73.8m 15.3% 15.4%

Compare with peers

Head to head: APT vs CVRXCVRX vs LNSRAPYX vs CVRX

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Cvrx, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Cvrx, Inc.